CVE-2025-36409: IBM ApplinX · Cross-site Scripting
Affects IBM ApplinXSource CVE Database V5
Not known to be exploited · CVSS 5.4 Medium.
Data as of 26 Oct 2026, 06:26 UTC
- EPSS
- 0.1% chance of exploitation in 30 days – higher than 7% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:NExploitation evidence
Disclosed: evidence found.
CVE published 20 Jan 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponised: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 2026-10-26.
What to do
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| IBMApplinX | Affected
| Fixed in– |
CPE configurations (1)
cpe:2.3:a:ibm:applinx:11.1:*:*:*:*:*:*:*
AI-suggested
1. Monitor IBM’s official channels for patches addressing CVE-2025-36409 and apply them promptly once available. 2. Until patches are released, implement strict input validation and output encoding on all user-supplied data within the ApplinX web UI to prevent script injection. 3. Restrict user privileges to the minimum necessary to reduce the risk of malicious script injection by authenticated users. 4. Employ Content Security Policy (CSP) headers to limit the execution of unauthorized scripts in the web interface. 5. Conduct regular security training for users to recognize and avoid triggering malicious scripts. 6. Monitor logs and user activities for unusual behavior indicative of exploitation attempts. 7. Consider network segmentation to isolate critical legacy systems accessed via ApplinX, limiting lateral movement if compromised. 8. Use multi-factor authentication to reduce the risk of credential compromise. 9. Review and harden session management mechanisms to prevent session hijacking. 10. Engage in periodic security assessments and penetration testing focused on web interface vulnerabilities.
Description
IBM ApplinX 11.1 is vulnerable to cross-site scripting. This vulnerability allows an authenticated user to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.